Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Parkinson Disease 4, Autosomal Dominant Lewy Body × Temozolomide × 90 days × Clear all

Sponsor

Conditions

Glioblastoma 48 Glioma 14 Brain Neoplasms 14 Neuroblastoma 10 Sarcoma, Ewing 8 Gliosarcoma 8 Astrocytoma 8 Medulloblastoma 7 Sarcoma 6 Rhabdomyosarcoma 6 Ependymoma 6 Recurrence 5 Osteosarcoma 5 Neoplasms 5 Melanoma 5 Diffuse Intrinsic Pontine Glioma 4 Small Cell Lung Carcinoma 3 Prostatic Neoplasms 3 Oligodendroglioma 3 Neoplasm Metastasis 3 Lymphoma 3 Colorectal Neoplasms 3 Wilms Tumor 2 Somatostatinoma 2 Rhabdoid Tumor 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroectodermal Tumors, Primitive 2 Lymphoma, Follicular 2

Interventions

pembrolizumab 50 Paclitaxel 14 Carboplatin 13 Cisplatin 12 lenvatinib 10 Pemetrexed 7 Saline Solution 5 Gemcitabine 5 Capecitabine 5 Albumin-Bound Paclitaxel 5 Oxaliplatin 4 Fluorouracil 4 Docetaxel 4 Bevacizumab 4 130-nm albumin-bound paclitaxel 4 patritumab deruxtecan 3 Leucovorin 3 olaparib 2 liposomal doxorubicin 2 enfortumab vedotin 2 Irinotecan 2 Histamine H2 Antagonists 2 Histamine Antagonists 2 Glucose 2 Dexamethasone 2 Cetuximab 2 Acetaminophen 2 zanidatamab 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡